Investor Relations

Contact Us

Corporate Contact Investor Relations Human Resources General Inquiries

FINANCIAL RESULTS
QIAGEN reports results for third quarter and first nine month of 2018
Open event
INFOGRAPHIC
Healthcare in 2025
OPEN
VIDEO
Explore our Video Hub
Visit Hub
Video Portal
video/mp4
NGS
The dawn of a new age
Read story
MICROBIOME RESEARCH
Behavior - it's all in our gut
Read Interview
TUBERCULOSIS
"Our goal is to develop easy and quick tests"
Read Interview

Latest press releases

SUBSCRIBE TO RSS-FEED

07.11.2018
QIAGEN N.V. announces successful completion of non-U.S. offer involving convertible notes
READ MORE
06.11.2018
QIAGEN N.V. launches non-US offering of cash settled convertible notes combined with convertible note hedge and warrant transactions
READ MORE
06.11.2018
Ad-hoc announcement pursuant to Art. 17 MAR
READ MORE
05.11.2018
QIAGEN launches new DNeasy Plant Pro Kit
READ MORE
29.10.2018
QIAGEN expands next-generation sequencing portfolio with oncology and immuno-oncology panels for research using GeneReader NGS System and other platforms
READ MORE
29.10.2018
QIAGEN expands QIAGEN Clinical Insight software to support all major sequencing platforms and assay types
READ MORE
29.10.2018
QIAGEN reports results for third quarter and first nine months of 2018
READ MORE
17.10.2018
QIAGEN announces winners of 2018 Microbiome Awards competition
READ MORE
15.10.2018
QIAGEN’s next-generation QIAstat-Dx system delivers fast, cost-effective diagnosis of gastrointestinal syndromes
READ MORE
11.10.2018
QIAGEN launches novel RNA-seq library preparation solutions for next-generation sequencing
READ MORE

SEE ALL RELEASES

At a glance

Key figures teaser

Key figures

Strategy teaser

Strategy

IR - Share data teaser

Share data

Shareholder structure

Corporate calendar

SEE ALL EVENTS

Financial reports

SEE ALL REPORTS

Our social media channels

Visit our Social Hub

Do you have further questions?

FOLLOW US ON SOCIAL MEDIA

LANGUAGE

OTHER WEBSITES

© QIAGEN 2013 - 18. All rights reserved